U.S. markets close in 42 minutes
  • S&P 500

    4,519.97
    +33.51 (+0.75%)
     
  • Dow 30

    35,445.97
    +187.36 (+0.53%)
     
  • Nasdaq

    15,133.78
    +111.97 (+0.75%)
     
  • Russell 2000

    2,276.26
    +8.42 (+0.37%)
     
  • Crude Oil

    82.92
    +0.48 (+0.58%)
     
  • Gold

    1,770.30
    +4.60 (+0.26%)
     
  • Silver

    23.72
    +0.46 (+1.96%)
     
  • EUR/USD

    1.1639
    +0.0020 (+0.17%)
     
  • 10-Yr Bond

    1.6350
    +0.0510 (+3.22%)
     
  • GBP/USD

    1.3797
    +0.0070 (+0.51%)
     
  • USD/JPY

    114.3300
    +0.0180 (+0.02%)
     
  • BTC-USD

    63,661.28
    +2,304.47 (+3.76%)
     
  • CMC Crypto 200

    1,473.60
    +10.24 (+0.70%)
     
  • FTSE 100

    7,217.53
    +13.70 (+0.19%)
     
  • Nikkei 225

    29,215.52
    +190.06 (+0.65%)
     

Accolade to Participate in Upcoming Investor Conferences

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

SEATTLE, May 10, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the following upcoming investor conferences:

  • The Bank of America 2021 Health Care Conference, including a presentation on Wednesday, May 12, 2021 at 8:45 a.m. E.T. An audio webcast and related presentation materials will be available at ir.accolade.com.

  • The 16th Annual Needham Virtual Technology & Media Conference, including a fireside chat on Thursday, May 20, 2021 at 8:00 a.m. E.T.

About Accolade, Inc.

Accolade provides personalized health and benefits solutions designed to empower every person to live their healthiest life. Accolade helps millions of people and their employers navigate the complexities of the healthcare system with empathy, expertise and through exceptional service while supporting them in lowering the cost of care and improving health outcomes. Accolade blends technology-enabled health and benefits solutions, specialized support from Accolade Health Assistants® and Clinicians and access to expert medical opinion services for high-cost treatment decisions. Accolade consistently receives consumer satisfaction ratings over 90 percent. For more information, visit Accolade on LinkedIn, Twitter, Instagram and Facebook and at www.accolade.com.

Investor Contact:

Todd Friedman, Investor Relations, 484-532-5200, Todd.Friedman@accolade.com

Asher Dewhurst, Investor Relations, 443-213-0500, accolade@westwicke.com

Media Contact:

Megan Torres, Public Relations, 206-926-8180, Megan.Torres@accolade.com

Source: Accolade